MX-1: Human Mammary Carcinoma

(actual study data; representative)
Parameter | Information |
---|---|
Strain | Outbred Athymic nu/nu |
Implant Type | Fragments |
Implant Location | SC, High Axilla |
Time to Staging | 7 days |
Time to 750mm3 | 15.9 days |
Td | 2.8 days |
(The above parameters are from one study. For further information on this cell line and other parameters, including different strains, vendors, implant type and location and/or standards of care, please contact Covance.)
***Please note that cell lines are not for sale and unavailable for purchase from Covance.***
Fill out our tumor models contact form to get started setting up your next preclinical study with us.
Histotype: Mammary/Breast
Tumor Line: Human
REF# 404
Related Cell Lines:
- BT-20
- BT-474
- HCC1395
- HCC70
- Hs 578Bst
- Hs 578T
- MCF-7
- MCF7-Luc-mCh-Puro
- MDA-MB-231
- MDA-MB-231-2LMP
- MDA-MB-231-Luc-D3H1
- MDA-MB-231-Luc-D3H2
- MDA-MB-231-Luc-D3H2LN
- MDA-MB-231-Luc-D3H3
- MDA-MB-361
- MDA-MB-453
- MDA-MB-468
- MX-1-Luc
- SK-BR-3
- T47D
- UISO-BCA-1
Related Model Spotlights:
- EMT-6 syngeneic breast tumor model – a powerful tool for immuno-oncology studies
- MDA-MB-231-luc-D3H2LN: A valuable model for triple-negative breast cancer research
- HCC70: A model of triple negative breast cancer
- Focal radiation enhances paclitaxel therapy in a mouse model of triple negative breast cancer